Subcellular Fate of Nanodelivery Systems

Weissig/Organelle-Specific Nanotechnology

Volumn , Issue , 2010, Pages 93-121

  Maysinger, Dusica ^a   Boridy, Sebastien ^a   Hutter, Eliza ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Biological responses to internalized metallic nanoparticles; Nanodelivery system subcellular fate; Nanogels and artificial chaperones

Indexed keywords

EID: 84883748328     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470875780.ch6     Document Type: Chapter

References (154)

1. Xia, T., Kovochich, M., and Nel, A. The role of reactive oxygen species and oxidative stress in mediating particulate matter injury . Clin. Occup. Environ. Med. 5: 817-836 (2006).
2. Maysinger, D. Nanoparticles and cells: good companions and doomed partnerships . Org. Biomol. Chem. 5:2335-2342 (2007).
3. Nel, A., Xia, T., Madler, L., and Li, N. Toxic potential of materials at the nanolevel . Science N.Y. 311:622-627 (2006).
4. Bae, Y. and Kataoka, K. Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers . Adv. Drug. Deliv. Rev. 61:768-784 (2009).
5. Aliabadi, H.M., Shahin, M., Brocks, D.R., and Lavasanifar, A. Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery . Clin. Pharmacokinet. 47:619-634 (2008).
6. Gilmore, J.L., Yi, X., Quan, L., and Kabanov, A. V. Novel nanomaterials for clinical neuroscience . J. Neuroimmune Pharmacol. 3:83-94 (2008).
7. Mikhail, A. S. and Allen, C. Block copolymer micelles for delivery of cancer therapy: Transport at the whole body, tissue and cellular levels . J. Control. Release 138:214-223 (2009).
8. Savic, R., Eisenberg, A., and Maysinger, D. Block copolymer micelles as delivery vehicles of hydrophobic drugs: micelle-cell interactions . J. Drug Target. 14:343-355 (2006).
9. Torchilin, V. P. Micellar nanocarriers: pharmaceutical perspectives . Pharm. Res. 24:1-16 (2007).
10. Gaucher, G., Dufresne, M.H., Sant, V.P., Kang, N., Maysinger, D., and Leroux , J. C. Block copolymer micelles: preparation, characterization and application in drug delivery . J. Control. Release 109:169-188 (2005).
11. Jain, M.P., Choi, A.O., Neibert, K.D., and Maysinger, D. Probing and preventing quantum dot-induced cytotoxicity with multimodal alpha-lipoic acid in multiple dimensions of the peripheral nervous system . Nanomedicine 4:277-290 (2009).
12. Kang, J. X. and Weylandt, K. H. Modulation of infl ammatory cytokines by omega-3 fatty acids . Subcell. Biochem. 49:133-143 (2008).
13. Serhan, C.N., Chiang, N., and Van Dyke, T. E. Resolving infl ammation: dual anti-infl ammatory and pro-resolution lipid mediators . Nat. Rev. Immunol. 8:349-361 (2008).
14. Alivisatos, A.P., Gu, W., and Larabell, C. Quantum dots as cellular probes . Annu. Rev. of Biomed. Eng. 7:55-76 (2005).
15. Delehanty, J.B., Mattoussi, H., and Medintz, I. L. Delivering quantum dots into cells: strategies, progress and remaining issues . Anal. Bioanal. Chem . 393:1091-1105 (2009).
16. Medintz, I.L., Mattoussi, H., and Clapp, A. R. Potential clinical applications of quantum dots . Int. J. Nanomed. 3:151-167 (2008).
17. Lovric, J., Cho, S.J., Winnik, F.M., and Maysinger, D. Unmodifi ed cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death . Chem. Biol. 12:1227-1234 (2005).
18. Giepmans, B.N., Adams, S.R., Ellisman, M.H., and Tsien, R. Y. The fl uorescent toolbox for assessing protein location and function . Science N.Y. 312:217-224 (2006).
19. Choi, H.S., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Itty Ipe, B., Bawendi , M.G., and Frangioni, J. V. Renal clearance of quantum dots . Nat. Biotechnol. 25:1165-1170 (2007).
20. Choi, H.S., Ipe, B.I., Misra, P., Lee, J.H., Bawendi, M.G., and Frangioni, J. V. Tissue-and organ-selective biodistribution of NIR fl uorescent quantum dots . Nano Lett. 9:2354-2359 (2009).
21. Fischer, H.C., Liu, L., Pang, K.S., and Chan, W. C. W. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat . Adv. Funct. Mater. 16:1299-1305 (2006).
22. Ryman-Rasmussen, J.P., Riviere, J.E., and Monteiro-Riviere, N. A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes . J. Invest. Dermatol. 127:143-153 (2007).
23. Ballou, B., Ernst, L.A., Andreko, S., Harper, T., Fitzpatrick, J.A., Waggoner , A.S., and Bruchez, M. P. Sentinel lymph node imaging using quantum dots in mouse tumor models . Bioconjug. Chem. 18:389-396 (2007).
24. Bentzen, E.L., Tomlinson, I.D., Mason, J., Gresch, P., Warnement, M.R., Wright, D., Sanders-Bush, E., Blakely, R., and Rosenthal, S. J. Surface modifi cation to reduce nonspecifi c binding of quantum dots in live cell assays . Bioconjug. Chem. 16:1488-1494 (2005).
25. Boulmedais, F., Bauchat, P., Brienne, M.J., Arnal, I., Artzner, F., Gacoin, T., Dahan, M., and Marchi-Artzner, V. Water-soluble pegylated quantum dots: from a composite hexagonal phase to isolated micelles . Langmuir 22:9797-9803 (2006).
26. Yu, W.W., Chang, E., Drezek, R., and Colvin, V. L. Water-soluble quantum dots for biomedical applications . Biochem. Biophys. Res. Commun. 348:781-786 (2006).
27. Gao, X., Cui, Y., Levenson, R.M., Chung, L.W., and Nie, S. In vivo cancer targeting and imaging with semiconductor quantum dots . Nat. Biotechnol. 22:969-976 (2004).
28. So, M.K., Xu, C., Loening, A.M., Gambhir, S.S., and Rao, J. Self-illuminating quantum dot conjugates for in vivo imaging . Nat. Biotechnol. 24:339-343 (2006).
29. Kim, S., Lim, Y.T., Soltesz, E.G., et al. Near-infrared fl uorescent type II quantum dots for sentinel lymph node mapping . Nat. Biotechnol. 22:93-97 (2004).
30. Frangioni, J.V., Kim, S.W., Ohnishi, S., Kim, S., and Bawendi, M. G. Sentinel lymph node mapping with type-II quantum dots . Methods Mol. Biol. (Clifton, N.J.) 374:147-160 (2007).
31. Inoue, Y., Izawa, K., Yoshikawa, K., Yamada, H., Tojo, A., and Ohtomo, K. In vivo fl uorescence imaging of the reticuloendothelial system using quantum dots in combination with bioluminescent tumour monitoring . Eur. J. Nucl. Med. Mol. Imaging 34:2048-2056 (2007).
32. Banati, R. B. Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain . Br. Med. Bull. 65:121-131 (2003).
33. Perry, V.H., Andersson, P.B., and Gordon, S. Macrophages and infl ammation in the central nervous system . Trends Neurosci. 16:268-273 (1993).
34. Behrendt, M., Sandros, M., McKinney, R., McDonald, K., Kriz, J., Przybytkowski , E., Tabrizian, M., and Maysinger, D. Cell imaging in real time and organelle distribution of fl uorescent InGaP/ZnS nanoparticles . Nanomedicine 4:747-761 (2009).
35. Maysinger, D., Behrendt, M., Lalancette-Hebert, M., and Kriz, J. Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles . Nano Lett. 7:2513-2520 (2007).
36. Ridet, A., Guillouf, C., Duchaud, E., Cundari, E., Fiore, M., Moustacchi, E., and Rosselli, F. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome . Cancer Res. 57:1722-1730 (1997).
37. Pekny, M. and Nilsson, M. Astrocyte activation and reactive gliosis . Glia 50:427-434 (2005).
38. Zhu, L., Ramboz, S., Hewitt, D., Boring, L., Grass, D.S., and Purchio, A. F. Non-invasive imaging of GFAP expression after neuronal damage in mice . Neurosci. Lett. 367:210-212 (2004).
39. Kadurugamuwa, J.L., Modi, K., Coquoz, O., Rice, B., Smith, S., Contag, P. R. , and Purchio, T. Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response . Infect. Immunity 73:7836-7843 (2005).
40. Zhang, L. W. and Monteiro-Riviere, N. A. Mechanism of quantum dot nanoparticle cellular uptake . Toxicol. Sci. 110:138-155 (2009).
41. Nabiev, I., Mitchell, S., Davies, A., et al. Nonfunctionalized nanocrystals can exploit a cell ' s active transport machinery delivering them to specifi c nuclear and cytoplasmic compartments . Nano Lett. 7:3452-3461 (2007).
42. Lovric, J., Bazzi, H.S., Cuie, Y., Fortin, G.R., Winnik, F.M., and Maysinger, D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots . J. Mol. Med. (Berlin) 83:377-385 (2005).
43. Choi, A.O., Brown, S.E., Szyf, M., and Maysinger, D. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells . J. Mol. Med. (Berlin) 86:291-302 (2008).
44. Ekgasit, S., Thammacharoen, C., Yu, F., and Knoll, W. Evanescent fi eld in surface plasmon resonance and surface plasmon fi eld-enhanced fl uorescence spectroscopies . Anal. Chem. 76:2210-2219 (2004).
45. Englebienne, P. Use of colloidal gold surface plasmon resonance peak shift to infer affi nity constants from the interactions between protein antigens and antibodies specifi c for single or multiple epitopes . Analyst 123:1599-1603 (1998).
46. Englebienne, P., Van Hoonacker, A., and Verhas, M. High-throughput screening using the surface plasmon resonance effect of colloidal gold nanoparticles . Analyst 126:1645-1651 (2001).
47. Watanabe, S., Sonobe, M., Arai, M., Tazume, Y., Matsuo, T., Nakamura, T., and Yoshida, K. Enhanced optical sensing of anions with amide-functionalized gold nanoparticles . Chem. Commun. 2866-2867 (2002).
48. Yu, C.X., Nakshatri, H., and Irudayaraj, J. Identity profi ling of cell surface markers by multiplex gold nanorod probes . Nano Lett. 7:2300-2306 (2007).
49. Yu, C. X. and Irudayaraj, J. Multiplex biosensor using gold nanorods . Anal. Chem. 79:572-579 (2007).
50. Lu, L.H., Ai, K., and Ozaki, Y. Environmentally friendly synthesis of highly monodisperse biocompatible gold nanoparticles with urchin-like shape . Langmuir 24:1058-1063 (2008).
51. Jain, P.K., Lee, K.S., El-Sayed, I.H., and El-Sayed, M. A. Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine . J. Phys. Chem. B 110:7238-7248 (2006).
52. Sau, T. K. and Murphy, C. J. Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution . J. Am. Chem. Soc. 126:8648-8649 (2004).
53. Nikoobakht, B. and El-Sayed, M. A. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method . Chem. Materials 15:1957-1962 (2003).
54. Bakr, O.M., Wunsch, B.H., and Stellacci, F. High-yield synthesis of multi-branched urchin-like gold nanoparticles . Chem. Materials 18:3297-3301 (2006).
55. Yu, K.F., Kelly, K.L., Sakai, N., and Tatsuma, T. Morphologies and surface plasmon resonance properties of monodisperse bumpy gold nanoparticles . Langmuir 24:5849-5854 (2008).
56. Wang, Y.W., Xie, X.Y., Wang, X.D., Ku, G., Gill, K.L., O ' Neal, D.P., Stoica , G., and Wang, L. V. Photoacoustic tomography of a nanoshell contrast agent in the in vivo rat brain . Nano Lett. 4:1689-1692 (2004).
57. Kim, D., Park, S., Lee, J.H., Jeong, Y.Y., and Jon, S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging . J. Am. Chem. Soc. 129:7661-7665 (2007).
58. Qian, X.M., Peng, X.H., Ansari, D.O., et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags . Nat. Biotechnol. 26:83-90 (2008).
59. Durr, N.J., Larson, T., Smith, D.K., Korgel, B.A., Sokolov, K., and Ben-Yakar , A. Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods . Nano Lett. 7:941-945 (2007).
60. Huff, T.B., Hansen, M.N., Zhao, Y., Cheng, J.X., and Wei, A. Controlling the cellular uptake of gold nanorods . Langmuir 23:1596-1599 (2007).
61. Wang, H.F., Huff, T.B., Zweifel, D.A., He, W., Low, P.S., Wei, A., and Cheng , J. X. In vitro and in vivo two-photon luminescence imaging of single gold nanorods . Proc. Nat. Acad. Sci. U.S.A. 102:15752-15756 (2005).
62. Bernardi, R., Lowery, A., Thompson, P., Blaney, S., and West, J. Immunonanoshells for targeted photothermal ablation in medulloblastoma and glioma: an in vitro evaluation using human cell lines . J. Neuro-Oncol. 86:165-172 (2008).
63. El-Sayed, I.H., Huang, X.H., and El-Sayed, M. A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles . Cancer Lett. 239:129-135 (2006).
64. O'Neal, D.P., Hirsch, L.R., Halas, N.J., Payne, J.D., and West, J. L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles . Cancer Lett. 209:171-176 (2004).
65. Huang, X.H., El-Sayed, I.H., Qian, W., and El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods . J. Am. Chem. Soc. 128:2115-2120 (2006).
66. Gannon, C., Patra, C., Bhattacharya, R., Mukherjee, P., and Curley, S. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells . J. Nanobiotechnol. 6:2 (2008).
67. Hainfeld, J.F., Slatkin, D.N., and Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice . Phys. Med. Biol. 49:N309-N315 (2004).
68. Rubin, P. and Levitt, S. H. The response of disseminated reticulum cell sarcoma to the intravenous injection of colloidal radioactive gold . J. Nucl. Med. 5:581-594 (1964).
69. Alfonso, A.E., Hassan, A., Gardner, B., Stein, S., Patti, J., Solomon, N.A., McCarthy, J., and Steigman, J. Prevention of hepatic metastases by intravenous radioactive gold . Cancer Res. 38:2740-2744 (1978).
70. Sau, T. K. and Murphy, C. J. Seeded high yield synthesis of short Au nanorods in aqueous solution . Langmuir 20:6414-6420 (2004).
71. Millstone, J.E., Metraux, G.S., and Mirkin, C. A. Controlling the edge length of gold nanoprisms via a seed-mediated approach . Adv. Functional Materials 16:1209-1214 (2006).
72. Lu, X.M., Yavuz, M.S., Tuan, H.Y., Korgel, B.A., and Xia, Y. N. Ultrathin gold nanowires can be obtained by reducing polymeric strands of oleylamine-AuCl complexes formed via aurophilic interaction . J. Am. Chem. Soc. 130:8900 (2008).
73. Shen, Z.R., Miyabayashi, K., Higashimoto, M., Shimoda, T., and Miyake, M. Single-crystalline gold nanodisks prepared by the shape transformation under UV irradiation from nanoparticles protected with discotic liquid crystalline ligands . Chem. Lett. 37:1276-1277 (2008).
74. Khoury, C. G. and Vo-Dinh, T. Gold nanostars for surface-enhanced Raman scattering: synthesis, characterization and optimization . J. Phys. Chem. C 112:18849-18859 (2008).
75. Kumar, P.S., Pastoriza-Santos, I., Rodriguez-Gonzalez, B., Garcia de Abajo , F.J., and Liz-Marzan, L. M. High-yield synthesis and optical response of gold nanostars . Nanotechnology 19:DOI:10.1088/0957-4484/19/01/015606 (2008).
76. Brown, C., Whitehouse, M., Tiekink, E., and Bushell, G. Colloidal metallic gold is not bio-inert . Infl ammopharmacology 16:133-137 (2008).
77. Connor, E.E., Mwamuka, J., Gole, A., Murphy, C.J., and Wyatt, M. D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity . Small 1:325-327 (2005).
78. Murphy, C.J., Gole, A.M., Stone, J.W., Sisco, P.N., Alkilany, A.M., Goldsmith , E.C., and Baxter, S. C. Gold nanoparticles in biology: beyond toxicity to cellular imaging . Acc. Chem. Res. 41:1721-1730 (2008).
79. Goodman, C.M., McCusker, C.D., Yilmaz, T., and Rotello, V. M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains . Bioconjug. Chem. 15:897-900 (2004).
80. Jiang, W., Kim, B.Y.S., Rutka, J.T., and Chan, W. C. W. Nanoparticle-mediated cellular response is size-dependent . Nat. Nanotechnol. 3:145-150 (2008).
81. Patra, H.K., Banerjee, S., Chaudhuri, U., Lahiri, P., and Dasgupta, A. K. Cell selective response to gold nanoparticles . Nanomed. Nanotechnol. Biol. Med. 3:111-119 (2007).
82. Hutter, E., Boridy, S., Labrecque, S., Lalancette-Hébert, M., Kriz, J., Winnik, F.M., and Maysinger, D. ACS Nano . 4:2595-2606 (2010).
83. De Jong, W.H., Hagens, W.I., Krystek, P., Burger, M.C., Sips, A.J.A.M., and Geertsma, R. E. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration . Biomaterials 29:1912-1919 (2008).
84. Sonavane, G., Tomoda, K., and Makino, K. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size . Colloids Surfaces B Biointerfaces 66:274-280 (2008).
85. Julián F. and Hillyer, R. M. A. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles . J. Pharm. Sci. 90:1927-1936 (2001).
86. Niidome, T., Yamagata, M., Okamoto, Y., Akiyama, Y., Takahashi, H., Kawano , T., Katayama, Y., and Niidome, Y. PEG-modifi ed gold nanorods with a stealth character for in vivo applications . J. Control. Release 114:343-347 (2006).
87. Nativo, P., Prior, I.A., and Brust, M. Uptake and intracellular fate of surface-modifi ed gold nanoparticles . ACS Nano 2:16390-1644 (2008).
88. Chithrani, B. D. and Chan, W. C. W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes . Nano Lett. 7:1542-1550 (2007).
89. Chithrani, B.D., Ghazani, A.A., and Chan, W. C. W. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells . Nano Lett. 6:662-668 (2006).
90. Gao, H., Shi, W., and Freund, L. B. Mechanics of receptor-mediated endocytosis . Proc. Nat. Acad. Sci. U.S.A. 102:9469-9474 (2005).
91. de la Fuente, J.M., Berry, C.C., Riehle, M.O., and Curtis, A. S. G. Nanoparticle targeting at cells . Langmuir 22:3286-3293 (2006).
92. Berry, C.C., de la Fuente, J.M., Mullin, M., Chu, S.W.L., and Curtis, A. S. G. Nuclear localization of HIV-1 Tat functionalized gold nanoparticles . NanoBioscience IEEE Trans. 6:262-269 (2007).
93. Tkachenko, A.G., Xie, H., Liu, Y., Coleman, D., Ryan, J., Glomm, W.R., Shipton, M.K., Franzen, S., and Feldheim, D. L. Cellular trajectories of peptide-modifi ed gold particle complexes: comparison of nuclear localization signals and peptide transduction domains . Bioconjug. Chem. 15:482-490 (2004).
94. Oyelere, A.K., Chen, P.C., Huang, X.H., El-Sayed, I.H., and El-Sayed, M. A. Peptide-conjugated gold nanorods for nuclear targeting . Bioconjug. Chem. 18:1490-1497 (2007).
95. Wagner, V., Dullaart, A., Bock, A.K., and Zweck, A. The emerging nanomedicine landscape . Nat. Biotechnol. 24:1211-1217 (2006).
96. Zhang, L., Gu, F.X., Chan, J.M., Wang, A.Z., Langer, R.S., and Farokhzad, O. C. Nanoparticles in medicine: therapeutic applications and developments . Clin. Pharmacol. Ther. 83:761-769 (2008).
97. Moghimi, S.M., Hunter, A.C., and Murray, J. C. Long-circulating and target-specifi c nanoparticles: theory to practice . Pharmacol. Rev. 53:283-318 (2001).
98. Panyam, J. and Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue . Adv. Drug Deliv. Rev. 55:329-347 (2003).
99. Bertin, P.A., Gibbs, J.M., Shen, C.K., Thaxton, C.S., Russin, W.A., Mirkin, C.A., and Nguyen, S. T. Multifunctional polymeric nanoparticles from diverse bioactive agents . J. Am. Chem. Soc. 128:4168-4169 (2006).
100. Vinogradov, S.V., Batrakova, E.V., and Kabanov, A. V. Nanogels for oligonucleotide delivery to the brain . Bioconjug. Chem. 15:50-60 (2004).
101. Patel, M.M., Goyal, B.R., Bhadada, S.V., Bhatt, J.S., and Amin, A. F. Getting into the brain: approaches to enhance brain drug delivery . CNS Drugs 23:35-58 (2009).
102. Lemieux, P., Vinogradov, S.V., Gebhart, C.L., et al. Block and graft copolymers and NanoGel copolymer networks for DNA delivery into cell . J. Drug Target. 8:91-105 (2000).
103. Ayame, H., Morimoto, N., and Akiyoshi, K. Self-assembled cationic nanogels for intracellular protein delivery . Bioconjug. Chem. 19:882-890 (2008).
104. Shimizu, T., Kishida, T., Hasegawa, U., Ueda, Y., Imanishi, J., Yamagishi, H., Akiyoshi, K., Otsuji, E., and Mazda, O . Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy . Biochem. Biophys. Res. Commun. 367:330-335 (2008).
105. Akiyoshi, K., Sasaki, Y., and Sunamoto, J. Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: thermal stabilization with refolding of carbonic anhydrase B . Bioconjug. Chem. 10:321-324 (1999).
106. Muchowski, P. J. and Wacker, J. L. Modulation of neurodegeneration by molecular chaperones . Nat. Rev. Neurosci. 6:11-22 (2005).
107. Akiyoshi, K., Deguchi, S., Moriguchi, N., Yamaguchi, S., and Sunamoto, J. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics . Macromolecules 26:3062-3068 (1993).
108. Akiyoshi, K., Deguchi, S., Tajima, H., Nishikawa, T., and Sunamoto, J. Microscopic structure and thermoresponsiveness of a hydrogel nanoparticle by self-assembly of a hydrophobized polysaccharide . Macromolecules 30:857-861 (1997).
109. Nomura, Y., Ikeda, M., Yamaguchi, N., Aoyama, Y., and Akiyoshi, K. Protein refolding assisted by self-assembled nanogels as novel artifi cial molecular chaperone . FEBS Lett. 553:271-276 (2003).
110. Asayama, W., Sawada, S., Taguchi, H., and Akiyoshi, K. Comparison of refolding activities between nanogel artifi cial chaperone and GroEL systems . Int. J. Biol. Macromol. 42:241-246 (2008).
111. Ikeda, K., Okada, T., Sawada, S., Akiyoshi, K., and Matsuzaki, K. Inhibition of the formation of amyloid beta-protein fi brils using biocompatible nanogels as artifi cial chaperones . FEBS Lett. 580:6587-6595 (2006).
112. Cabaleiro-Lago, C., Quinlan-Pluck, F., Lynch, I., Lindman, S., Minogue, A.M., Thulin, E., Walsh, D.M., Dawson, K.A., and Linse, S. Inhibition of amyloid beta protein fi brillation by polymeric nanoparticles . J. Am. Chem. Soc. 130:15437-15443 (2008).
113. Heegaard, P.M., Boas, U., and Otzen, D. E. Dendrimer effects on peptide and protein fi brillation . Macromol. Biosci. 7:1047-1059 (2007).
114. Hasegawa, U., Nomura, S.M., Kaul, S.C., Hirano, T., and Akiyoshi, K. Nanogel-quantum dot hybrid nanoparticles for live cell imaging . Biochem. Biophys. Res. Commun. 331:917-921 (2005).
115. Toita, S., Hasegawa, U., Koga, H., Sekiya, I., Muneta, T., and Akiyoshi, K. Protein-conjugated quantum dots effectively delivered into living cells by a cationic nanogel . J. Nanosci. Nanotechnol. 8:2279-2285 (2008).
116. Fukui, T., Kobayashi, H., Hasegawa, U., Nagasawa, T., Akiyoshi, K., and Ishikawa , I. Intracellular delivery of nanogel-quantum dot hybrid nanoparticles into human periodontal ligament cells . Drug Metab. Lett. 1:131-135 (2007).
117. Frautschy, S.A., Yang, F., Irrizarry, M., Hyman, B., Saido, T.C., Hsiao, K., and Cole, G. M. Microglial response to amyloid plaques in APPsw transgenic mice . Am. J. Pathol. 152:307-317 (1998).
118. McGeer, P.L., Itagaki, S., Tago, H., and McGeer, E. G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR . Neurosci. Lett. 79:195-200 (1987).
119. Boridy, S., Takahashi, H., Akiyoshi, K., and Maysinger, D. The binding of pullulan modifi ed cholesterol nanogel to Abeta oligomers and their suppression of cytotoxicity Biomaterials 30:5583-5591 (2009).
120. Selkoe, D. J. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior . Behav. Brain. Res. 192:106-113 (2008).
121. Kitano, S., Kageyama, S., Nagata, Y., et al. HER2-specifi c T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan . Clin. Cancer Res. 12:7397-7405 (2006).
122. Kageyama, S., Kitano, S., Hirayama, M., et al. Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogel . Cancer Sci. 99:601-607 (2008).
123. Cho, S.J., Maysinger, D., Jain, M., Roder, B., Hackbarth, S., and Winnik, F. M. Long-term exposure to CdTe quantum dots causes functional impairments in live cells . Langmuir 23:1974-1980 (2007).
124. Choi, A.O., Cho, S.J., Desbarats, J., Lovric, J., and Maysinger, D. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells . J. Nanobiotechnol. 5:1 (2007).
125. Mamelak, M. Alzheimer's disease, oxidative stress and gammahydroxybutyrate . Neurobiol. Aging, 28:1340-1360 (2007).
126. Moreira, P.I., Santos, M.S., and Oliveira, C. R. Alzheimer's disease: a lesson from mitochondrial dysfunction . Antioxidants & Redox Signaling 9:1621-1630 (2007).
127. Morinaga, A., Hirohata, M., Ono, K., and Yamada, M. Estrogen has anti-amyloidogenic effects on Alzheimer's beta-amyloid fi brils in vitro . Biochem. Biophys. Res. Commun. 359:697-702 (2007).
128. Zhu, X., Su, B., Wang, X., Smith, M.A., and Perry, G. Causes of oxidative stress in Alzheimer disease . Cell Mol. Life Sci. 64:2202-2210 (2007).
129. Li, N., Sioutas, C., Cho, A., et al. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage . Environ. Health Perspect. 111:455-460 (2003).
130. Castranova, V. Signaling pathways controlling the production of infl ammatory mediators in response to crystalline silica exposure: role of reactive oxygen/ nitrogen species . Free Radic. Biol. Med. 37:916-925 (2004).
131. Bell, A. T. The impact of nanoscience on heterogeneous catalysis . Science N.Y. 299:1688-1691 (2003).
132. Halliwell, B. and Gutteridge, J. M. Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts . Arch. Biochem. Biophys. 246:501-514 (1986).
133. Li, N., Hao, M., Phalen, R.F., Hinds, W.C., and Nel, A. E. Particulate air pollutants and asthma. A paradigm for the role of oxidative stress in PM-induced adverse health effects . Clin. Immunol. 109:250-265 (2003).
134. Xiao, G.G., Wang, M., Li, N., Loo, J.A., and Nel, A. E. Use of proteomics to demonstrate a hierarchical oxidative stress response to diesel exhaust particle chemicals in a macrophage cell line . J. Biol. Chem. 278:50781-50790 (2003).
135. Foged, C., Brodin, B., Frokjaer, S., and Sundblad, A. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model . Int. J. Pharm. 298:315-322 (2005).
136. Chan, K. and Kan, Y. W. Nrf2 is essential for protection against acute pulmonary injury in mice . Proc. Nat. Acad. Sci. U.S.A. 96:12731-12736 (1999).
137. Li, N., Alam, J., Venkatesan, M.I., et al. Nrf2 is a key transcription factor that regulates antioxidant defense in macrophages and epithelial cells: protecting against the proinfl ammatory and oxidizing effects of diesel exhaust chemicals . J. Immunol. 173:3467-3481 (2004).
138. Talalay, P., Dinkova-Kostova, A.T., and Holtzclaw, W. D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis . Adv. Enzyme Regul. 43:121-134 (2003).
139. Dinkova-Kostova, A.T., Liby, K.T., Stephenson, K.K., et al. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and infl ammatory stress . Proc. Nat. Acad. Sci. U.S.A. 102:4584-4589 (2005).
140. Fine, J.M., Gordon, T., Chen, L.C., Kinney, P., Falcone, G., and Beckett, W. S. Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value . J. Occup. Environ. Med. 39:722-726 (1997).
141. Ho, G.J., Drego, R., Hakimian, E., and Masliah, E. Mechanisms of cell signaling and infl ammation in Alzheimer's disease . Curr. Drug Targets Infl amm. Allergy 4:247-256 (2005).
142. Sayes, C.M., Wahi, R., Kurian, P.A., Liu, Y., West, J.L., Ausman, K.D., Warheit, D.B., and Colvin, V. L. Correlating nanoscale titania structure with toxicity: a cytotoxicity and infl ammatory response study with human dermal fi broblasts and human lung epithelial cells . Toxicol. Sci. 92:174-185 (2006).
143. Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., and Maxfield, F. R. Activation of microglia acidifi es lysosomes and leads to degradation of Alzheimer amyloid fi brils . Mol. Biol. Cell. 18:1490-1496 (2007).
144. Jaffrey, S. R. and Snyder, S. H. Nitric oxide: a neural messenger . Annu. Rev. Cell Dev. Biol. 11:417-440 (1995).
145. Nathan, C. and Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls . Cell 78:915-918 (1994).
146. Aksenova, M.V., Aksenov, M.Y., Mactutus, C.F., and Booze, R. M. Cell culture models of oxidative stress and injury in the central nervous system . Curr. Neurovasc. Res. 2:73-89 (2005).
147. Garthwaite, J. and Boulton, C. L. Nitric oxide signaling in the central nervous system . Annu. Rev. Physiol. 57:683-706 (1995).
148. Saha, R. N. and Pahan, K. Regulation of inducible nitric oxide synthase gene in glial cells . Antioxid. Redox Signal. 8:929-947 (2006).
149. Galea, E., Feinstein, D.L., and Reis, D. J. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures . Proc. Natl. Acad. Sci. U.S.A. 89:10945-10949 (1992).
150. Jana, M., Anderson, J.A., Saha, R.N., Liu, X., and Pahan, K. Regulation of inducible nitric oxide synthase in proinfl ammatory cytokine-stimulated human primary astrocytes . Free Radic. Biol. Med. 38:655-664 (2005).
151. Trajkovic, V., Stosic-Grujicic, S., Samardzic, T., Markovic, M., Miljkovic, D., Ramic, Z., and Mostarica Stojkovic, M. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes . J. Neuroimmunol. 119:183-191 (2001).
152. Perry, G., Avila, J., Kinoshita, J., and Smith, M. A. Alzheimer's Disease: A Century of Scientifi c and Clinical Research . IOS Press, Amsterdam, 2006 .
153. Mustacich, D. and Powis, G. Thioredoxin reductase . Biochem. J. 346 (Pt 1): 1-8 (2000).
154. Venardos, K. M. and Kaye, D. M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review . Curr. Med. Chem. 14:1539-1549 (2007).